Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis

International Journal of Molecular Sciences

Volumn 10, Issue 9, 2009, Pages 4187-4197

  Pongsavee, Malinee ^a   Patmasiriwat, Pimpicha ^b   Saunders, Grady F ^c  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BRCA1 missense mutation; Breast ovarian carcinogenesis; Estrogen; Estrogen receptor signaling pathway

Indexed keywords

BRCA1 PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER FAMILY; CANCER PATIENT; CANCER RISK; CASE REPORT; CELL CYCLE; CELL PROLIFERATION; ENZYME ACTIVITY; FAMILIAL CANCER; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; ONCOGENE C MYC; ONSET AGE; OVARY CANCER; PEDIGREE ANALYSIS; THAILAND; TUMOR SUPPRESSOR GENE;

BRCA1 MISSENSE MUTATION; BREAST/OVARIAN CARCINOGENESIS; ESTROGEN; ESTROGEN RECEPTOR SIGNALING PATHWAY;

ADENOCARCINOMA; ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOGENESIS; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION, MISSENSE; OVARIAN NEOPLASMS; PEDIGREE; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 70350043057     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10094187     Document Type: Article

References (38)

1. Rahman, N.; Stratton, M.R. The genetics of breast cancer susceptibility. Annu. Rev. Genet. 1998, 32, 95-121.
2. Miki, Y.; Swensen, J.; Shattuck-Eidens, D.; Futreal, P.A.; Harshman, K.; Tavtigian, S.; Liu, Q.; Cochran, C.; Bennett, M.; Ding, W.; Bell, R.; Rosenthal, J.; Hussey, C.; Tran, T.; McClure, M.; Frye, C.; Hattier, T.; Phelps, R.; Haugen-Strano, A.; Katcher, H.; Yakumo, K.; Gholami, Z.; Shaffer, D.; Stone, S.; Bayer, S.; Wray, C.; Bogden, R.; Dayananth, P.; Ward, J.; Tonin, P.; Narod, S.; Bristow, P.K.; Norris, F.H.; Helvering, L.; Morris, P.; Rosteck, P.; Lai, M.; Barrett, J.C.; Lewis, C.; Neuhausen, S.; Cannon-Albright, L.; Goldgar, D.; Wiseman, R.; Kamb, A.; Skolnick, M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71. (Pubitemid 24345325)
3. Jensen, D.E.; Proctor, M.; Marquis, S.T.; Gardner, H.P.; Ha, S.I.; Chodosh, L.A.; Ishov, A.M.; Tommerup, N.; Vissing, H.; Sekido, Y.; Minna, J.; Borodovsky, A.; Schultz, D.C.; Wilkinson, K.D.; Maul, G.G.; Barlev, N.; Berger, S.L.; Prendergast, G.C.; Rauscher, F.J., 3rd. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1- mediated cell growth suppression. Oncogene 1998, 16, 1097-1112.
4. Hashizume, R.; Fukuda, M.; Maeda, I.; Nishikawa, H.; Oyake, D.; Yabuki, Y.; Ogata, H.; Ohata, T. The ring heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancerderived mutation. J. Bio. Chem. 2001, 276, 14537-14540. (Pubitemid 37373320)
5. Monterio, A.N.; August, A.; Hanafusa, H. Evidence for a transcriptional activation of BRCA1 Cterminal region. Proc. Natl. Acad. Sci. USA 1996, 93, 13595-13599. (Pubitemid 26424164)
6. Callebaut, I.; Mormon, J.P. From BRCA1 to RAP1: A widespread BRCT module closely associated with DNA repair. FEBS Lett. 1997, 400, 25-30.
7. George, F.W.; Wilson, J.D. The Physiology of Reproduction; Knobil, E., Ed.; New York Press Inc.: New York, NY, USA, 1988; pp. 2-27.
8. Jensen, E.V. Nuclear Hormone Receptors; Parker, M.J., Ed.; Academic Press: London, UK, 1992; pp. 1-13.
9. Hilakivi-Clarke, L.; Onojafe, I.; Raygada, M.; Cho, E.; Lippman, M.E. A method diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc. Natl. Acad. Sci. USA 1997, 94, 9372-9377.
10. Gudas, J.M.; Nguyen, H.; Li, T.; Cowan, K.H. Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res. 1995, 55, 4561-4565.
11. Liehr, J.G. Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 2000, 21, 40-54.
12. Enmark, E.; Gustafsson, J.A. Oestrogen receptors-An overview. J. Intern. Med. 1999, 246, 133-138.
13. Halachmi, S.; Marden, E.; Martin, G.; MacKay, H.; Abbondanza, C.; Brown, M. Estrogen receptor-associated protein: Possible mediators of hormone-induced transcription. Science 1994, 264, 1455-1458. (Pubitemid 24217135)
14. Fan, S.; Wang, J.A.; Yuan, R.; Ma, Y.; Meng, Q.; Erdos, M.R.; Pestell, R.G.; Yuan, F.; Auborn, K.J.; Goldberg, I.D.; Rosen, E.M. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 1999, 284, 1354-1356.
15. Keen, J.C.; Davidson, N.E. The biology of breast carcinoma. Cancer 2003, 97, 825-833.
16. Patmasiriwat, P.; Bhothisuwan, K.; Sinilnikova, O.M.; Chopin, S.; Methakijvaroon, S.; Badzioch, M.; Padungsutt, P.; Vattanaviboon, P.; Vattanasapt, V.; Szabo, C.I.; Saunders, G.F.; Goldgar, D.; Lenoir, G.M. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Human Mutat. 2002, 20, 230.
17. Couse, J.; Korach, K. Estrogen receptor null mice: What have we learned and where will they lead us? Endocrinol. Rev. 1999, 20, 358-417. (Pubitemid 30654784)
18. Colditz, G. Relationship between estrogen level, use of hormone replacement therapy, and breast cancer. J. Natl. Cancer Inst. 1998, 90, 814-823. (Pubitemid 28280547)
19. Migliaccio, A.; Domenico, M.; Castoria, G.; de Falco, A.; Bontempo, P.; Nola, E.; Auricchio, F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 1996, 15, 1292-1300. (Pubitemid 26093465)
20. Castoria, G.; Barone, M.; Domenico, M.; Bilancio, A.; Ametrano, D.; Migliaccio, A.; Auricchio, F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J. 1999, 18, 2500-2510. (Pubitemid 29213282)
21. Sutherland, R.; Reddel, R.; Green, M. Effects of oestrogen on cell proliferation and cell cycle kinetics: A hypothesis on the cell cycle effects of antioestrogens. Eur. J. Cancer Clin. Oncol. 1983, 19, 307-318.
22. Leung, B.; Potter, A. Mode of estrogen action on cell proliferation in CAMA-1 cells, sensitivity of G1 phase population. J. Cell Biochem. 1987, 34, 213-225. (Pubitemid 17089661)
23. Zuppan, P.; Hall, J.M.; Lee, M.K.; Ponglikitmongkol, M.; King, M.C. Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am. J. Hum. Genet. 1991, 48, 1065.
24. Zheng, L.; Annab, L.A.; Afshari, C.A.; Lee, W.H.; Boyer, T.G. BRCA1 mediates ligandindependent transcriptional repression of the estrogen receptor. Proc. Natl. Acad. Sci. USA 2001, 98, 9587-9592.
25. Pestell, R.G.; Albanese, C.; Benlens, A.T.; Segall, J.F.; Lee, B.J.; Arnold, A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr. Rev. 1999, 20, 501-534. (Pubitemid 30647078)
26. Prall, O.; Carroll, J.; Sutherland, R. A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to active cyclin E-CDK2. J. Bio. Chem. 2001, 276, 45433-45442. (Pubitemid 37391342)
27. Carroll, J.; Swarbrick, A.; Musgrove, E.; Sutherland, R. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: Implications for the antiproliferative effects of antiestrogens. Cancer Res. 2002, 62, 3126-3131. (Pubitemid 34602404)
28. Mawson, A.; Lai, A.; Carroll, J.; Sergio, M.; Mitchell, C.; Sarcevic, B. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol. Cell Endocrinol. 2005, 229, 161-173.
29. Prall, O.W.; Rogan, E.M.; Musgrove, E.A.; Watts, C.K.; Sutherland, R.L. Estrogen-induced activation of Cdk4 and Cdk2 during G I-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem. 1997, 272, 10882-10894. (Pubitemid 27181106)
30. Lai, A.; Sarcevic, B.; Prall, O.; Sutherland, R. Insulin/insulin-like growth-I and estrogen cooperate to stimulate cyclin E-CDK2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21 WAF1/Cip1. J. Biol. Chem. 2001, 276, 25823-25833. (Pubitemid 37412784)
31. Starita, L.M.; Parvin, J.D. The multiple nuclear functions of BRCA1: Transcription, ubiquitination and DNA repair. Curr. Opin. Cell Biol. 2003, 15, 345-350. (Pubitemid 36638654)
32. Lorick, K.L.; Jensen, J.P.M.; Fang, S.; Ong, A.M.; Hatakeyama, S.; Weissman, A.M. Ring finger mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA 1999, 96, 11364-11369.
33. Xia, Y.; Pao, G.M.; Chen, H.W.; Vema, I.M.; Hunter, T. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 2003, 278, 5255-5263. (Pubitemid 36801039)
34. Mallery, D.L.; Vandenberg, C.J.; Hiom, K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 2002, 21, 6755-6762. (Pubitemid 36014547)
35. Hashizume, R.M.; Fukuda, M.; Maeda, I.; Nishikawa, H.; Oyake, D.; Yabuki, Y.; Otaga, H.; Ohta, T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Bio. Chem. 2001, 276, 14537-14540. (Pubitemid 37373320)
36. Brzovic, P.S.; Keeffe, J.R.; Nishikawa, H.; Miyamoto, K.; Fox, D.; Fukuda, M.; Ohta, T.; Klevit, R. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin ligase complex. Proc. Natl. Acad. Sci. USA 2003, 100, 5646-5651.
37. Morris, J.R.; Pangon, L.M.; Boutell, C.; Katagiri, T.; Keep, N.H.; Solomon, E. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum. Mol. Genet. 2006, 15, 599-606. (Pubitemid 43205424)
38. Morris, J.R.; Solomon, E. BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum. Mol. Genet. 2004, 13, 807-817.